期刊文献+

甘草酸差向异构体在大鼠体内的药动学研究 被引量:7

Pharmacokinetics of 2 epimers of glycyrrhizic acid in rats
下载PDF
导出
摘要 目的研究甘草酸的差向异构体在大鼠体内的药物动力学特征。方法大鼠按25mg.kg-1的剂量分别灌胃给予甘草酸2种差向异构体,使用HPLC测定血药浓度,以DAS2.0软件拟合药动学参数,并用SPSS统计软件对α-甘草酸组和β-甘草酸组的药动学参数进行比较。结果甘草酸的差向异构体在体内转化为甘草次酸后主要药动学参数分别为:α-甘草酸组AUC0-36为(57.04±14.64)μg.mL-1.h,Cmax为(4.68±2.56)μg.mL-1t1/2为(5.56±1.65)h,tmax为(10.0±4.0)h;β-甘草酸组AUC0-36为(36.55±13.18)μg.mL-1.h,Cmax为(4.24±1.69)μg.mL-1,t1/2为(7.88±2.40)h,tmax为(9.0±1.1)h。结论甘草酸的差向异构体在体内转化为甘草次酸后的主要药动学参数存在显著性差异。 Objective To determine the pharmacokinetic parameters of 2 epimers of glycyrrhizic acid (GL) after oral administration of α-GL and β-GL in rats.Methods α-GL and β-GL solvent were administered orally at a dose of 25 mg·kg-1.The concentration in the plasma was measured by HPLC method.Experimental data and the pharmacokinetic parameters were processed with the computer program DAS 2.0 and SPSS.Results The main pharmacokinetic parameters were:AUC0-36=(57.04±14.64)μg·mL-1·h;Cmax= (4.68±2.56)μg·mL-1 t1/2=(5.56±1.65)h,tmax=(10.0±4.0)h after oral administration of α-GL;AUC0-36=(36.55±13.18)μg·mL-1·h;Cmax=(4.24±1.69)μg·mL-1,t1/2=(7.88±2.40)h,tmax=(9.0±1.1)h respectively after oral administration of β-GL.Conclusion The main pharmacokinetic parameters of GA after the oral administration of α-GL and β-GL are different.
出处 《中南药学》 CAS 2010年第5期350-353,共4页 Central South Pharmacy
关键词 甘草酸 甘草次酸 差向异构体 药物动力学 glycyrrhizic acid glycyrrhetic acid epimer pharmacokinetics
  • 相关文献

参考文献14

  • 1田娟,周彦彬,左英,冉黎灵,厉宇红,丁劲松.HPLC-MS-MS测定人血浆中的甘草次酸及生物利用度[J].中南药学,2007,5(5):475-478. 被引量:6
  • 2Akamatsu H,Komura J,Asada Y,et al.Mechanism of anti-inflammatory action of glycyrrhizin:effect on neutrophil functions including reactive oxygen species generation[J].Planta Medi-ca,1991,57 (2):119-121.
  • 3Zhang LX,Wang BE.Randomized clinical trial with two doses (100 and 40 mL) of stronger neo-minophagen C in Chinese patients with chronic hepatitis B[J].Hepatol Res,2002,24 (3):220-227.
  • 4Van-Rossum TG,Vulto AG,Hop WC,et al.Glycyrrhizin-in-duced reduction of ALT in Europe patients with chronic hepatitis C[J].AMJ Gastroenterol,2001,96 (8):2432-2437.
  • 5Pliasunova OA,Egoricheva IN,Fediuk NV,et al.The anti-HIV activity of beta-glycyrrhizic acid[J].Voprosy Virusolo-gii,1992,37 (5-6):235-238.
  • 6Nagai T,Egashira T,Kudo Y,et al.Attenuation of dysfunction in he ischemia-reperfused liver by glycyrrhizin[J].Japanese Journal of Pharmacology,1992,58 (3):209-218.
  • 7Cinatl J,Morgenstern B,Bauer G,et al.Glycyrrhizin,an active component of liquorice roots,and replication of SARS-asso-ciated coronavirus[J].Lancet,2003,361 (9374):2045-2046.
  • 8Chan HT,Chan C,Ho JW.Inhibition of glycyrrhizic acid on aflatoxin Bl-induced cytotoxicity in hepatoma cells[J].Toxicology,2003,188 (223):211-217.
  • 9吴锡铭,吕坚,茹仁萍.甘草酸18H差向异构体的比较研究[J].中国药学杂志,1993,28(4):215-218. 被引量:21
  • 10吴锡铭,吕坚.甘草酸差向异构体对大鼠肝损害的治疗作用[J].中国药理学报,1992,13(4):370-374. 被引量:24

二级参考文献56

共引文献193

同被引文献88

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部